AIDS Meds: Founded & Operated by People with HIVPOZ logo
Back to home » Top Stories » CROI 2008
CROI 2008 15th Conference on Retroviruses and Opportunistic Infections
Boston, MA
February 3-8, 2008

Good Bacteria Reduces Vaginal HIV Levels

February 9, 2008

By Tim Horn

Healthy bacteria limits the amount of HIV detected in the genital secretions of women infected with the virus, according to new research presented this week at the 15th Conference on Retroviruses and Opportunistic Infections (CROI). The presenting authors hope that their findings, suggesting that HIV-positive women with healthy levels of vaginal Lactobacillus may be less likely to transmit the virus, will lead to additional research testing Lactobacillus supplementation as a potential prevention strategy.

The research was presented at CROI by Jane Hitti, MD, associate professor of obstetrics and gynecology at the University of Washington (UW) School of Medicine in Seattle and colleagues at UW and the University of Rochester Medical Center in Rochester.

Dr. Hitti’s group examined the mix of bacteria in the vaginas of 57 HIV-positive women. They monitored vaginal levels of Lactobacillus as well as hydrogen peroxide, which is produced by the bacteria and is believed to hinder the virus (as well as the overgrowth of harmful bacteria and fungi).

The Lactobacillus bacteria normally found in the vagina is a close cousin of the healthy bacteria detected in the small intestine and often found in yogurt.

Every three months or so—for an average of two years—the researchers also monitored HIV levels in genital secretions from the women, also looking out for sexually transmitted infections like trichomoniasis, gonorrhea and chlamydia.

While test tube studies previously indicated that Lactobacillus might help prevent HIV infection in women, Dr. Hitti’s group actually established a strong association between decreased levels of the virus in the vagina with the presence of hydrogen peroxide-producing Lactobacillus. Dr. Hitti reported that, when Lactobacillus was present in the women’s vaginas, there was a threefold reduction in their genital secretion viral loads. 

The researchers also found that the amount of the virus in the vagina varied, in step with the presence of Lactobacillus. Women who had low levels of the bacteria during early clinic visits, but then had higher levels of Lactobacillus during subsequent visits, saw their vaginal HIV levels drop.  Similarly, vaginal HIV levels increased in women in whom the good bacteria had disappeared between visits.

“These findings underscore the importance of maintaining a healthy, Lactobacillus-dominant vaginal flora for HIV-positive women,” said Dr. Hitti. “I hope that we can explore Lactobacillus replacement in the future for women who do not have this bacteria, as a strategy to decrease the amount of HIV in the vagina.”

NEW! Scroll down to comment on this story.

Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

j kenny ireland, ireland, 2008-03-11 07:46:50
oregano oil - taken as food supplement - is a good aid to control fungi and harmful bacteria. spillanthes as a tincture - an african paracress- is also good. natural yogurt and raw garlic are also very beneficial to maintain a healthy internal eco system.you can buy pill form pro biotics - Udos super 5's and Super 8's are good. Molkosan Whey supplement is excellent also.

Bruce S, Campbell, 2008-02-13 14:20:01
How does one increase the probiotics in the vagina?

comments 1 - 2 (of 2 total)    

Our general CROI conference coverage was sponsored by Abbott Laboratories, Boehringer Ingelheim and Gilead Sciences.

Additional funding, to support news and video coverage of women's issues at CROI, was provided by Tibotec Therapeutics.

More from CROI 2008

Starting and Switching Treatment
February 9, 2008

Durable Efficacy and Safety With Isentress Treatment

February 7, 2008

Durable Efficacy Seen in Studies of New NNRTI Intelence

Once-Daily Viramune Is at Least as Efficient as Twice-Daily Dosing

February 6, 2008

TDM-Guided PI Dose Increases of Limited Benefit

February 5, 2008

Once- vs. Twice-Daily Kaletra Tablets: Similar Safety and Potency

Epzicom Comparable to Truvada as First-Line NRTI Choice

February 4, 2008

Norvir/Reyataz Comparable to Kaletra for First-Line Therapy



HIV/AIDS Complications and Treatment Side Effects
February 4, 2008

Abacavir, Didanosine Linked to Increased Heart Attack Risk

Sexual Reinfection With HCV Following Treatment



Experimental HIV Drugs
February 12, 2008

VIRxSYS Gene Therapy Makes Progress

February 9, 2008

Prezista Effective and Safe in Positive Kids

February 7, 2008

Nanotechnology May Yield Long-Lasting Meds

February 4, 2008

Vicriviroc Shows Well in Treatment-Experienced Patients



HIV Transmission and Prevention
February 9, 2008

Good Bacteria Reduces Vaginal HIV Levels

February 6, 2008

Male Circumcision Doesn't Reduce Women's HIV Risk



Expert Interviews
February 12, 2008

Women & HIV Treatment

World of Prevention: Vaccines and More

Condom-Free Sex? Controversial Swiss Declaration

February 11, 2008

New Hope for Treatment Experienced

February 8, 2008

HIV & Your Heart: Part I

HIV & Your Heart: Part II

Morris Jackson: Survivor and Treatment Activist

February 7, 2008

Prevention and Women: HIV-positive and HIV-negative

February 6, 2008

Refining HIV Treatment for New Med Takers

February 5, 2008

AIDS Survival: Progress Not Perfection


© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy